| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V51515 | (R,R)-VVD-118313 | 2875046-31-2 | (R,R)-VVD-118313 is the seven bodies of VVD-118313. |
|
V116152 | CPA-7 | 16961-77-6 | CPA7 is a novel Stat3 inhibitor. |
|
V132509 | CSF1R-IN-26 | CSF1R-IN-26 is a CSF-1R inhibitor with an IC50 value of 20.07 nM. | |
|
V134002 | DM245 | 3106606-60-1 | DM245 is an EPAC1 activator and STAT3 phosphorylation inhibitor with a target pIC50 value of 4.801. |
|
V136386 | Fulipiftide | 2868985-56-0 | Fulipiftide is a short peptide derived from pigment epithelial-derived factor (PEDF). |
|
V138225 | JAK2-IN-13 | JAK2-IN-13 is a potent and orally effective JAK2 inhibitor with an IC50 value of 54.7 nM. | |
|
V119602 | KB-15 | KB-15 is a STAT3 inhibitor. | |
|
V139908 | MG-3C | MG-3C is a potent inhibitor of matrix metalloproteinase 9 (MMP-9). | |
|
V140479 | mTOR/STAT3-IN-1 | mTOR/STAT3-IN-1 is a dual mTOR/STAT3 inhibitor. | |
|
V104628 | STAT3 HiBiT degrader 1 | 2767166-30-1 | STAT3 HiBiT Degrader 1 is a STAT3 HiBiT degrader with DC50 < 0.05 μM in A549 cells. |
|
V104788 | STAT3-IN-38 | 3033049-16-7 | STAT3-IN-38 (Compound 4m) is a STAT3 inhibitor (KD for rhSTAT3: 45.33 µM) and a derivative of Celastrol. |
|
V145293 | STAT3-IN-40 | 3053241-01-0 | STAT3-IN-40 is an anticancer drug. |
|
V118505 | STAT6 degrader-3 | 3077464-19-5 | STAT6 degrader-3 (compound I-1) is a highly efficient and selective STAT6 degrader with a DC50 < 1 nM. |
|
V111865 | STAT6 ligand-2 | STAT6 ligand-1 is a ligand of STAT6. | |
|
V145304 | STAT6-IN-6 | 2952725-20-9 | STAT6-IN-6 is a selective STAT6 inhibitor. |
|
V79653 | Syk-IN-6 | 3018859-95-2 | Syk-IN-6 is an inhibitor (blocker/antagonist) of lipid-SH2 domain interactions and controls the cellular activity of SH2 domain-containing kinases. |